These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predictors of defibrillation energy requirements with nonepicardial lead systems. Kopp DE; Blakeman BP; Kall JG; Olshansky B; Kinder CA; Wilber DJ Pacing Clin Electrophysiol; 1995 Feb; 18(2):253-60. PubMed ID: 7731873 [TBL] [Abstract][Full Text] [Related]
4. Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Rashba EJ; Shorofsky SR; Brown T; Peters RW; Gold MR Heart Rhythm; 2005 Jan; 2(1):49-54. PubMed ID: 15851265 [TBL] [Abstract][Full Text] [Related]
5. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators. Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Swiatecka G Kardiol Pol; 2005 Apr; 62(4):317-28; discussion 329-31. PubMed ID: 15928737 [TBL] [Abstract][Full Text] [Related]
6. Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment. Kühlkamp V; Mewis C; Suchalla R; Mermi J; Dörnberger V; Seipel L Int J Cardiol; 1999 Jun; 69(3):271-9. PubMed ID: 10402110 [TBL] [Abstract][Full Text] [Related]
7. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation. Leong-Sit P; Gula LJ; Diamantouros P; Krahn AD; Skanes AC; Yee R; Klein GJ Am Heart J; 2006 Dec; 152(6):1104-8. PubMed ID: 17161062 [TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized evaluation of a nonthoracotomy implantable cardioverter defibrillator lead system. Endotak/PRX Investigator Group. Baker JH; Epstein AE; Voshage-Stahl L Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):72-8. PubMed ID: 9121974 [TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of defibrillation energy requirements. Neuzner J; Bahawar H; Berkowitsch A; Michel U; Schlepper M; Pitschner HF Am J Cardiol; 1997 Jan; 79(2):205-6. PubMed ID: 9193027 [TBL] [Abstract][Full Text] [Related]
10. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810 [TBL] [Abstract][Full Text] [Related]
11. Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system. Raitt MH; Johnson G; Dolack GL; Poole JE; Kudenchuk PJ; Bardy GH J Am Coll Cardiol; 1995 Jun; 25(7):1576-83. PubMed ID: 7759708 [TBL] [Abstract][Full Text] [Related]